|
|
Volumn 61, Issue 4, 2014, Pages 963-965
|
|
Incidence of anti-HLA donor specific antibodies in liver-transplant patients given mTOR inhibitors without calcineurin inhibitors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCINEURIN INHIBITOR;
CYCLOSPORIN A;
DONOR SPECIFIC ANTIBODY;
EVEROLIMUS;
HLA ANTIBODY;
HLA DQ3 ANTIBODY;
HLA DQ5 ANTIBODY;
HLA DR1 ANTIBODY;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
STEROID;
TACROLIMUS;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ANTIBIOTIC;
TARGET OF RAPAMYCIN KINASE;
ACUTE GRAFT REJECTION;
ADULT;
ANTIBODY DETECTION;
ANTIBODY SCREENING;
CANCER RECURRENCE;
CHOLESTASIS;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
HUMAN;
HYPERTRANSAMINASEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY FUNCTION;
LETTER;
LIVER CELL CARCINOMA;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MIDDLE AGED;
PRIORITY JOURNAL;
UNSPECIFIED SIDE EFFECT;
ADVERSE EFFECTS;
ANTAGONISTS AND INHIBITORS;
ANTIBODY PRODUCTION;
DRUG EFFECTS;
FRANCE;
GRAFT REJECTION;
IMMUNOLOGY;
PROCEDURES;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADULT;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIBODY FORMATION;
CALCINEURIN INHIBITORS;
FEMALE;
FRANCE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
INCIDENCE;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SIROLIMUS;
TOR SERINE-THREONINE KINASES;
TREATMENT OUTCOME;
|
|
EID: 84926362724
PISSN: 01688278
EISSN: 16000641
Source Type: Journal
DOI: 10.1016/j.jhep.2014.06.029 Document Type: Letter |
|
Times cited : (7)
|
|
References (10)
|
